ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Infertility Services Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: June 2025
|
Report Code: QYRE-Auto-3I6321
Home | Market Reports | Health| Reproductive Health
Global Infertility Services Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Infertility Services Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-3I6321
Report
June 2025
Pages:160
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife AB
INVO Bioscience
Irvine Scientific
NMC Health
OB GYN Associates
TriHealth
Virtus Health
Mayo Clinic
LIVZON
Abbott
Theramex
Cinnagen
InVitroCare
Jinxin Fertility
Caerus Biotech

Infertility Services Market Size

In 2024, the global market size of Infertility Services was estimated to be worth US$ 7698 million and is forecast to reach approximately US$ 12610 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.

Infertility Services Market

Infertility Services Market

Infertility services refer to medical procedures and treatments that are designed to help individuals or couples who are experiencing difficulties in conceiving a child. These services aim to diagnose and treat the underlying causes of infertility, and potentially assist in achieving a successful pregnancy.
Infertility services have become an important part of the global medical field in recent years. With the change of lifestyle, the influence of environmental factors and the change of fertility concepts, infertility has gradually become an important social and health issue worldwide. According to statistics from the World Health Organization (WHO), about 10-15% of couples in the world face infertility problems. This proportion varies in different countries and regions, but the prevalence of this problem has prompted the rapid development of the infertility treatment market.
At present, the scale of the infertility service market is growing globally and is expected to continue to grow in the next few years. The rapid development of assisted reproductive technology (ART) has given hope to many couples who were once unable to get pregnant. The maturity of technologies such as in vitro fertilization (IVF), egg freezing, intracytoplasmic sperm injection (ICSI), and embryo genetic screening (PGS/PGD) has not only increased the success rate, but also allowed more infertile patients to enjoy treatment. In addition, with the advancement of genetic testing technology, the popularization of preimplantation genetic screening can effectively reduce the risk of chromosomal abnormalities and increase the chance of successful pregnancy.
Despite the rapid growth of the infertility service market, it still faces some challenges and problems:
High treatment costs: Assisted reproductive technologies such as IVF are expensive and not all families can afford them. Especially in some developing countries or regions, although the technology is gradually becoming popular, the cost of treatment is still a major obstacle. Therefore, how to reduce treatment costs and provide more economical treatment options is still a difficult problem that needs to be solved. Differences in technology accessibility: Although some advanced assisted reproductive technologies have been popularized in some developed countries, in many developing countries and regions, these technologies are not yet popular and the accessibility of treatment is low. In addition, the imbalance of medical facilities has caused a gap in the treatment of infertility in patients in different regions and industries.
With the continuous advancement of science and technology and the increase in social needs, the future development trend of the infertility service market is becoming clearer and clearer.
The core manufacturers of global infertility services include Ferring Pharmaceuticals, Merck, Jinxin Fertility, Vitrolife, Mayo Clinic and LIVZON. The top three manufacturers account for approximately 24% of the global share. The Asia-Pacific region is the world's largest market, accounting for nearly 45% of the market share.
In terms of product type, assisted reproductive technology (ART) occupies a dominant position, accounting for 62% of the market share. At the same time, in terms of application, females are the largest application field, accounting for 66%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Infertility Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infertility Services.
The Infertility Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Infertility Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infertility Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Infertility Services Market Report

Report Metric Details
Report Name Infertility Services Market
Forecasted market size in 2031 approximately US$ 12610 million
CAGR 7.4%
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Male
  • Female
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Ferring Pharmaceuticals, Merck, Jinxin Fertility, Vitrolife, Mayo Clinic, LIVZON, Abbott, Monash IVF, CARE Facility, Theramex, TriHealth, NMC Health, CooperSurgical, Irvine Scientific, Virtus Health, CinnaGen, OB GYN Associates, Caerus Biotech, InVitroCare, INVO Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Infertility Services in global and regional level.
  • Chapter 3: Detailed analysis of Infertility Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Infertility Services revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Infertility Services Market size in 2031?

Ans: The Infertility Services Market size in 2031 will be approximately US$ 12610 million.

What is the market share of major companies in Infertility Services Market?

Ans: The top three manufacturers account for approximately 24% of the global share.

What is the Infertility Services Market share by region?

Ans: The Asia-Pacific region is the world's largest market, accounting for nearly 45% of the market share.

What is the Infertility Services Market share by type?

Ans: In terms of product type, assisted reproductive technology (ART) occupies a dominant position, accounting for 62% of the market share.

Who are the main players in the Infertility Services Market report?

Ans: The main players in the Infertility Services Market are Ferring Pharmaceuticals, Merck, Jinxin Fertility, Vitrolife, Mayo Clinic, LIVZON, Abbott, Monash IVF, CARE Facility, Theramex, TriHealth, NMC Health, CooperSurgical, Irvine Scientific, Virtus Health, CinnaGen, OB GYN Associates, Caerus Biotech, InVitroCare, INVO Bioscience

What are the Application segmentation covered in the Infertility Services Market report?

Ans: The Applications covered in the Infertility Services Market report are Male, Female

What are the Type segmentation covered in the Infertility Services Market report?

Ans: The Types covered in the Infertility Services Market report are Assisted Reproductive Technology (ART), Infertility Drug Services, Others

Recommended Reports

Infertility Treatments

Assisted Reproductive Services

Related Genetic Testing

1 Study Coverage
1.1 Infertility Services Product Introduction
1.2 Market by Type
1.2.1 Global Infertility Services Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Assisted Reproductive Technology (ART)
1.2.3 Infertility Drug Services
1.2.4 Others
1.3 Market by Application
1.3.1 Global Infertility Services Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Male
1.3.3 Female
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Infertility Services Market Size Estimates and Forecasts
2.2 Infertility Services Market Size by Region: 2024 Versus 2031
2.2.1 Global Infertility Services Revenue by Region: 2020-2025
2.2.2 Global Infertility Services Revenue Forecast by Region (2026-2031)
2.2.3 Global Infertility Services Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Infertility Services Revenue by Type (2020-2031)
3.1.2 Global Infertility Services Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Infertility Services Revenue by Application (2020-2031)
3.2.2 Global Infertility Services Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Assisted Reproductive Technology (ART) of Infertility Services Revenue Market Share by Application
3.3.2 Infertility Drug Services of Infertility Services Revenue Market Share by Application
3.3.3 Others of Infertility Services Revenue Market Share by Application
4 Global Infertility Services by Company
4.1 Global Infertility Services Revenue by Company (2020-2025)
4.2 Global Infertility Services Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Infertility Services Companies around the World: Ranking by Revenue
4.3.2 Global Infertility Services Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Infertility Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Infertility Services Companies Headquarters & Product Type
4.4.1 Global Infertility Services Companies Headquarters
4.4.2 Date of International Companies Enter into Infertility Services Market
4.4.3 Global Infertility Services Companies Product & Service
4.4.4 Assisted Reproductive Technology (ART) Revenue Market Share of Infertility Services by Company
4.4.5 Infertility Drug Services Revenue Market Share of Infertility Services by Company
4.4.6 Others Revenue Market Share of Infertility Services by Company
4.5 Global Infertility Services Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Ferring Pharmaceuticals
5.1.1 Ferring Pharmaceuticals Corporation Information
5.1.2 Ferring Pharmaceuticals Description, Business Overview
5.1.3 Ferring Pharmaceuticals Infertility Services Products Offered
5.1.4 Ferring Pharmaceuticals Infertility Services Revenue and Gross Margin (2020-2025)
5.1.5 Ferring Pharmaceuticals Infertility Services Revenue by Product in 2024
5.1.6 Ferring Pharmaceuticals Infertility Services Revenue by Application in 2024
5.1.7 Ferring Pharmaceuticals Infertility Services Revenue by Geographic Area in 2024
5.1.8 Ferring Pharmaceuticals Recent Developments
5.2 Merck
5.2.1 Merck Corporation Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Infertility Services Products Offered
5.2.4 Merck Infertility Services Revenue and Gross Margin (2020-2025)
5.2.5 Merck Infertility Services Revenue by Product in 2024
5.2.6 Merck Infertility Services Revenue by Application in 2024
5.2.7 Merck Infertility Services Revenue by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Jinxin Fertility
5.3.1 Jinxin Fertility Corporation Information
5.3.2 Jinxin Fertility Description, Business Overview
5.3.3 Jinxin Fertility Infertility Services Products Offered
5.3.4 Jinxin Fertility Infertility Services Revenue and Gross Margin (2020-2025)
5.3.5 Jinxin Fertility Infertility Services Revenue by Product in 2024
5.3.6 Jinxin Fertility Infertility Services Revenue by Application in 2024
5.3.7 Jinxin Fertility Infertility Services Revenue by Geographic Area in 2024
5.3.8 Jinxin Fertility Recent Developments
5.4 Vitrolife
5.4.1 Vitrolife Corporation Information
5.4.2 Vitrolife Description, Business Overview
5.4.3 Vitrolife Infertility Services Products Offered
5.4.4 Vitrolife Infertility Services Revenue and Gross Margin (2020-2025)
5.4.5 Vitrolife Infertility Services Revenue by Product in 2024
5.4.6 Vitrolife Infertility Services Revenue by Application in 2024
5.4.7 Vitrolife Infertility Services Revenue by Geographic Area in 2024
5.4.8 Vitrolife Recent Developments
5.5 Mayo Clinic
5.5.1 Mayo Clinic Corporation Information
5.5.2 Mayo Clinic Description, Business Overview
5.5.3 Mayo Clinic Infertility Services Products Offered
5.5.4 Mayo Clinic Infertility Services Revenue and Gross Margin (2020-2025)
5.5.5 Mayo Clinic Infertility Services Revenue by Product in 2024
5.5.6 Mayo Clinic Infertility Services Revenue by Application in 2024
5.5.7 Mayo Clinic Infertility Services Revenue by Geographic Area in 2024
5.5.8 Mayo Clinic Recent Developments
5.6 LIVZON
5.6.1 LIVZON Corporation Information
5.6.2 LIVZON Description, Business Overview
5.6.3 LIVZON Infertility Services Products Offered
5.6.4 LIVZON Infertility Services Revenue and Gross Margin (2020-2025)
5.6.5 LIVZON Infertility Services Revenue by Product in 2024
5.6.6 LIVZON Infertility Services Revenue by Application in 2024
5.6.7 LIVZON Infertility Services Revenue by Geographic Area in 2024
5.6.8 LIVZON Recent Developments
5.7 Abbott
5.7.1 Abbott Corporation Information
5.7.2 Abbott Description, Business Overview
5.7.3 Abbott Infertility Services Products Offered
5.7.4 Abbott Infertility Services Revenue and Gross Margin (2020-2025)
5.7.5 Abbott Infertility Services Revenue by Product in 2024
5.7.6 Abbott Infertility Services Revenue by Application in 2024
5.7.7 Abbott Infertility Services Revenue by Geographic Area in 2024
5.7.8 Abbott Recent Developments
5.8 Monash IVF
5.8.1 Monash IVF Corporation Information
5.8.2 Monash IVF Description, Business Overview
5.8.3 Monash IVF Infertility Services Products Offered
5.8.4 Monash IVF Infertility Services Revenue and Gross Margin (2020-2025)
5.8.5 Monash IVF Infertility Services Revenue by Product in 2024
5.8.6 Monash IVF Infertility Services Revenue by Application in 2024
5.8.7 Monash IVF Infertility Services Revenue by Geographic Area in 2024
5.8.8 Monash IVF Recent Developments
5.9 CARE Facility
5.9.1 CARE Facility Corporation Information
5.9.2 CARE Facility Description, Business Overview
5.9.3 CARE Facility Infertility Services Products Offered
5.9.4 CARE Facility Infertility Services Revenue and Gross Margin (2020-2025)
5.9.5 CARE Facility Infertility Services Revenue by Product in 2024
5.9.6 CARE Facility Infertility Services Revenue by Application in 2024
5.9.7 CARE Facility Infertility Services Revenue by Geographic Area in 2024
5.9.8 CARE Facility Recent Developments
5.10 Theramex
5.10.1 Theramex Corporation Information
5.10.2 Theramex Description, Business Overview
5.10.3 Theramex Infertility Services Products Offered
5.10.4 Theramex Infertility Services Revenue and Gross Margin (2020-2025)
5.10.5 Theramex Infertility Services Revenue by Product in 2024
5.10.6 Theramex Infertility Services Revenue by Application in 2024
5.10.7 Theramex Infertility Services Revenue by Geographic Area in 2024
5.10.8 Theramex Recent Developments
5.11 TriHealth
5.11.1 TriHealth Corporation Information
5.11.2 TriHealth Description, Business Overview
5.11.3 TriHealth Infertility Services Products Offered
5.11.4 TriHealth Infertility Services Revenue and Gross Margin (2020-2025)
5.11.5 TriHealth Infertility Services Revenue by Product in 2024
5.11.6 TriHealth Infertility Services Revenue by Application in 2024
5.11.7 TriHealth Infertility Services Revenue by Geographic Area in 2024
5.11.8 TriHealth Recent Developments
5.12 NMC Health
5.12.1 NMC Health Corporation Information
5.12.2 NMC Health Description, Business Overview
5.12.3 NMC Health Infertility Services Products Offered
5.12.4 NMC Health Infertility Services Revenue and Gross Margin (2020-2025)
5.12.5 NMC Health Infertility Services Revenue by Product in 2024
5.12.6 NMC Health Infertility Services Revenue by Application in 2024
5.12.7 NMC Health Infertility Services Revenue by Geographic Area in 2024
5.12.8 NMC Health Recent Developments
5.13 CooperSurgical
5.13.1 CooperSurgical Corporation Information
5.13.2 CooperSurgical Description, Business Overview
5.13.3 CooperSurgical Infertility Services Products Offered
5.13.4 CooperSurgical Infertility Services Revenue and Gross Margin (2020-2025)
5.13.5 CooperSurgical Infertility Services Revenue by Product in 2024
5.13.6 CooperSurgical Infertility Services Revenue by Application in 2024
5.13.7 CooperSurgical Infertility Services Revenue by Geographic Area in 2024
5.13.8 CooperSurgical Recent Developments
5.14 Irvine Scientific
5.14.1 Irvine Scientific Corporation Information
5.14.2 Irvine Scientific Description, Business Overview
5.14.3 Irvine Scientific Infertility Services Products Offered
5.14.4 Irvine Scientific Infertility Services Revenue and Gross Margin (2020-2025)
5.14.5 Irvine Scientific Infertility Services Revenue by Product in 2024
5.14.6 Irvine Scientific Infertility Services Revenue by Application in 2024
5.14.7 Irvine Scientific Infertility Services Revenue by Geographic Area in 2024
5.14.8 Irvine Scientific Recent Developments
5.15 Virtus Health
5.15.1 Virtus Health Corporation Information
5.15.2 Virtus Health Description, Business Overview
5.15.3 Virtus Health Infertility Services Products Offered
5.15.4 Virtus Health Infertility Services Revenue and Gross Margin (2020-2025)
5.15.5 Virtus Health Infertility Services Revenue by Product in 2024
5.15.6 Virtus Health Infertility Services Revenue by Application in 2024
5.15.7 Virtus Health Infertility Services Revenue by Geographic Area in 2024
5.15.8 Virtus Health Recent Developments
5.16 CinnaGen
5.16.1 CinnaGen Corporation Information
5.16.2 CinnaGen Description, Business Overview
5.16.3 CinnaGen Infertility Services Products Offered
5.16.4 CinnaGen Infertility Services Revenue and Gross Margin (2020-2025)
5.16.5 CinnaGen Infertility Services Revenue by Product in 2024
5.16.6 CinnaGen Infertility Services Revenue by Application in 2024
5.16.7 CinnaGen Infertility Services Revenue by Geographic Area in 2024
5.16.8 CinnaGen Recent Developments
5.17 OB GYN Associates
5.17.1 OB GYN Associates Corporation Information
5.17.2 OB GYN Associates Description, Business Overview
5.17.3 OB GYN Associates Infertility Services Products Offered
5.17.4 OB GYN Associates Infertility Services Revenue and Gross Margin (2020-2025)
5.17.5 OB GYN Associates Infertility Services Revenue by Product in 2024
5.17.6 OB GYN Associates Infertility Services Revenue by Application in 2024
5.17.7 OB GYN Associates Infertility Services Revenue by Geographic Area in 2024
5.17.8 OB GYN Associates Recent Developments
5.18 Caerus Biotech
5.18.1 Caerus Biotech Corporation Information
5.18.2 Caerus Biotech Description, Business Overview
5.18.3 Caerus Biotech Infertility Services Products Offered
5.18.4 Caerus Biotech Infertility Services Revenue and Gross Margin (2020-2025)
5.18.5 Caerus Biotech Infertility Services Revenue by Product in 2024
5.18.6 Caerus Biotech Infertility Services Revenue by Application in 2024
5.18.7 Caerus Biotech Infertility Services Revenue by Geographic Area in 2024
5.18.8 Caerus Biotech Recent Developments
5.19 InVitroCare
5.19.1 InVitroCare Corporation Information
5.19.2 InVitroCare Description, Business Overview
5.19.3 InVitroCare Infertility Services Products Offered
5.19.4 InVitroCare Infertility Services Revenue and Gross Margin (2020-2025)
5.19.5 InVitroCare Infertility Services Revenue by Product in 2024
5.19.6 InVitroCare Infertility Services Revenue by Application in 2024
5.19.7 InVitroCare Infertility Services Revenue by Geographic Area in 2024
5.19.8 InVitroCare Recent Developments
5.20 INVO Bioscience
5.20.1 INVO Bioscience Corporation Information
5.20.2 INVO Bioscience Description, Business Overview
5.20.3 INVO Bioscience Infertility Services Products Offered
5.20.4 INVO Bioscience Infertility Services Revenue and Gross Margin (2020-2025)
5.20.5 INVO Bioscience Infertility Services Revenue by Product in 2024
5.20.6 INVO Bioscience Infertility Services Revenue by Application in 2024
5.20.7 INVO Bioscience Infertility Services Revenue by Geographic Area in 2024
5.20.8 INVO Bioscience Recent Developments
6 North America
6.1 North America Infertility Services Market Size YoY Growth 2020-2031
6.2 North America Infertility Services Market Facts & Figures by Country (2020-2031)
6.3 North America Infertility Services Revenue by Type (2020-2025)
6.4 North America Infertility Services Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Infertility Services Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Infertility Services Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Infertility Services Revenue by Type (2020-2025)
7.4 Asia-Pacific Infertility Services Revenue by Application (2020-2025)
8 Europe
8.1 Europe Infertility Services Market Size YoY Growth 2020-2031
8.2 Europe Infertility Services Market Facts & Figures by Country (2020-2031)
8.3 Europe Infertility Services Revenue by Type (2020-2025)
8.4 Europe Infertility Services Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Infertility Services Market Size YoY Growth 2020-2031
9.2 Latin America Infertility Services Market Facts & Figures by Country (2020-2031)
9.3 Latin America Infertility Services Revenue by Type (2020-2025)
9.4 Latin America Infertility Services Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Infertility Services Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Infertility Services Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Infertility Services Revenue by Type (2020-2025)
10.4 Middle East and Africa Infertility Services Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Infertility Services Supply Chain Analysis
11.2 Infertility Services Key Raw Materials and Upstream Suppliers
11.3 Infertility Services Clients Analysis
11.4 Infertility Services Sales Channel and Sales Model Analysis
11.4.1 Infertility Services Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Infertility Services Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Infertility Services Distributors
12 Infertility Services Market Dynamics
12.1 Infertility Services Industry Trends
12.2 Infertility Services Market Drivers
12.3 Infertility Services Market Challenges
12.4 Infertility Services Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
CARE facility
CooperSurgical
Ferring Pharmaceuticals
Monash IVF
Merck
Vitrolife AB
INVO Bioscience
Irvine Scientific
NMC Health
OB GYN Associates
TriHealth
Virtus Health
Mayo Clinic
LIVZON
Abbott
Theramex
Cinnagen
InVitroCare
Jinxin Fertility
Caerus Biotech
List of Tables
 Table 1. Global Infertility Services Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Infertility Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Infertility Services Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Infertility Services Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Infertility Services Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Infertility Services Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Infertility Services Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Infertility Services Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Infertility Services Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Infertility Services Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Infertility Services Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Infertility Services Players by Revenue (US$ Million) in 2024
 Table 13. Global Infertility Services Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Infertility Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infertility Services as of 2024)
 Table 15. Global Infertility Services Companies Headquarters
 Table 16. Date of International Companies Enter into Infertility Services Market
 Table 17. Global Infertility Services Companies Product & Service
 Table 18. Global Infertility Services Mergers & Acquisitions, Expansion Plans
 Table 19. Ferring Pharmaceuticals Corporation Information
 Table 20. Ferring Pharmaceuticals Description and Business Overview
 Table 21. Ferring Pharmaceuticals Infertility Services Product
 Table 22. Ferring Pharmaceuticals Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Ferring Pharmaceuticals Revenue Proportion of Infertility Services by Product in 2024
 Table 24. Ferring Pharmaceuticals Revenue Proportion of Infertility Services by Application in 2024
 Table 25. Ferring Pharmaceuticals Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 26. Ferring Pharmaceuticals Recent Developments
 Table 27. Merck Corporation Information
 Table 28. Merck Description and Business Overview
 Table 29. Merck Infertility Services Product
 Table 30. Merck Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Merck Revenue Proportion of Infertility Services by Product in 2024
 Table 32. Merck Revenue Proportion of Infertility Services by Application in 2024
 Table 33. Merck Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 34. Merck Recent Developments
 Table 35. Jinxin Fertility Corporation Information
 Table 36. Jinxin Fertility Description and Business Overview
 Table 37. Jinxin Fertility Infertility Services Product
 Table 38. Jinxin Fertility Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. Jinxin Fertility Revenue Proportion of Infertility Services by Product in 2024
 Table 40. Jinxin Fertility Revenue Proportion of Infertility Services by Application in 2024
 Table 41. Jinxin Fertility Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 42. Jinxin Fertility Recent Developments
 Table 43. Vitrolife Corporation Information
 Table 44. Vitrolife Description and Business Overview
 Table 45. Vitrolife Infertility Services Product
 Table 46. Vitrolife Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. Vitrolife Revenue Proportion of Infertility Services by Product in 2024
 Table 48. Vitrolife Revenue Proportion of Infertility Services by Application in 2024
 Table 49. Vitrolife Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 50. Vitrolife Recent Developments
 Table 51. Mayo Clinic Corporation Information
 Table 52. Mayo Clinic Description and Business Overview
 Table 53. Mayo Clinic Infertility Services Product
 Table 54. Mayo Clinic Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Mayo Clinic Revenue Proportion of Infertility Services by Product in 2024
 Table 56. Mayo Clinic Revenue Proportion of Infertility Services by Application in 2024
 Table 57. Mayo Clinic Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 58. Mayo Clinic Recent Developments
 Table 59. LIVZON Corporation Information
 Table 60. LIVZON Description and Business Overview
 Table 61. LIVZON Infertility Services Product
 Table 62. LIVZON Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. LIVZON Revenue Proportion of Infertility Services by Product in 2024
 Table 64. LIVZON Revenue Proportion of Infertility Services by Application in 2024
 Table 65. LIVZON Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 66. LIVZON Recent Developments
 Table 67. Abbott Corporation Information
 Table 68. Abbott Description and Business Overview
 Table 69. Abbott Infertility Services Product
 Table 70. Abbott Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Abbott Revenue Proportion of Infertility Services by Product in 2024
 Table 72. Abbott Revenue Proportion of Infertility Services by Application in 2024
 Table 73. Abbott Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 74. Abbott Recent Developments
 Table 75. Monash IVF Corporation Information
 Table 76. Monash IVF Description and Business Overview
 Table 77. Monash IVF Infertility Services Product
 Table 78. Monash IVF Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. Monash IVF Revenue Proportion of Infertility Services by Product in 2024
 Table 80. Monash IVF Revenue Proportion of Infertility Services by Application in 2024
 Table 81. Monash IVF Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 82. Monash IVF Recent Developments
 Table 83. CARE Facility Corporation Information
 Table 84. CARE Facility Description and Business Overview
 Table 85. CARE Facility Infertility Services Product
 Table 86. CARE Facility Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. CARE Facility Revenue Proportion of Infertility Services by Product in 2024
 Table 88. CARE Facility Revenue Proportion of Infertility Services by Application in 2024
 Table 89. CARE Facility Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 90. CARE Facility Recent Developments
 Table 91. Theramex Corporation Information
 Table 92. Theramex Description and Business Overview
 Table 93. Theramex Infertility Services Product
 Table 94. Theramex Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. Theramex Revenue Proportion of Infertility Services by Product in 2024
 Table 96. Theramex Revenue Proportion of Infertility Services by Application in 2024
 Table 97. Theramex Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 98. Theramex Recent Developments
 Table 99. TriHealth Corporation Information
 Table 100. TriHealth Description and Business Overview
 Table 101. TriHealth Infertility Services Product
 Table 102. TriHealth Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. TriHealth Revenue Proportion of Infertility Services by Product in 2024
 Table 104. TriHealth Revenue Proportion of Infertility Services by Application in 2024
 Table 105. TriHealth Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 106. TriHealth Recent Developments
 Table 107. NMC Health Corporation Information
 Table 108. NMC Health Description and Business Overview
 Table 109. NMC Health Infertility Services Product
 Table 110. NMC Health Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 111. NMC Health Revenue Proportion of Infertility Services by Product in 2024
 Table 112. NMC Health Revenue Proportion of Infertility Services by Application in 2024
 Table 113. NMC Health Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 114. NMC Health Recent Developments
 Table 115. CooperSurgical Corporation Information
 Table 116. CooperSurgical Description and Business Overview
 Table 117. CooperSurgical Infertility Services Product
 Table 118. CooperSurgical Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 119. CooperSurgical Revenue Proportion of Infertility Services by Product in 2024
 Table 120. CooperSurgical Revenue Proportion of Infertility Services by Application in 2024
 Table 121. CooperSurgical Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 122. CooperSurgical Recent Developments
 Table 123. Irvine Scientific Corporation Information
 Table 124. Irvine Scientific Description and Business Overview
 Table 125. Irvine Scientific Infertility Services Product
 Table 126. Irvine Scientific Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 127. Irvine Scientific Revenue Proportion of Infertility Services by Product in 2024
 Table 128. Irvine Scientific Revenue Proportion of Infertility Services by Application in 2024
 Table 129. Irvine Scientific Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 130. Irvine Scientific Recent Developments
 Table 131. Virtus Health Corporation Information
 Table 132. Virtus Health Description and Business Overview
 Table 133. Virtus Health Infertility Services Product
 Table 134. Virtus Health Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 135. Virtus Health Revenue Proportion of Infertility Services by Product in 2024
 Table 136. Virtus Health Revenue Proportion of Infertility Services by Application in 2024
 Table 137. Virtus Health Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 138. Virtus Health Recent Developments
 Table 139. CinnaGen Corporation Information
 Table 140. CinnaGen Description and Business Overview
 Table 141. CinnaGen Infertility Services Product
 Table 142. CinnaGen Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 143. CinnaGen Revenue Proportion of Infertility Services by Product in 2024
 Table 144. CinnaGen Revenue Proportion of Infertility Services by Application in 2024
 Table 145. CinnaGen Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 146. CinnaGen Recent Developments
 Table 147. OB GYN Associates Corporation Information
 Table 148. OB GYN Associates Description and Business Overview
 Table 149. OB GYN Associates Infertility Services Product
 Table 150. OB GYN Associates Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 151. OB GYN Associates Revenue Proportion of Infertility Services by Product in 2024
 Table 152. OB GYN Associates Revenue Proportion of Infertility Services by Application in 2024
 Table 153. OB GYN Associates Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 154. OB GYN Associates Recent Developments
 Table 155. Caerus Biotech Corporation Information
 Table 156. Caerus Biotech Description and Business Overview
 Table 157. Caerus Biotech Infertility Services Product
 Table 158. Caerus Biotech Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 159. Caerus Biotech Revenue Proportion of Infertility Services by Product in 2024
 Table 160. Caerus Biotech Revenue Proportion of Infertility Services by Application in 2024
 Table 161. Caerus Biotech Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 162. Caerus Biotech Recent Developments
 Table 163. InVitroCare Corporation Information
 Table 164. InVitroCare Description and Business Overview
 Table 165. InVitroCare Infertility Services Product
 Table 166. InVitroCare Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 167. InVitroCare Revenue Proportion of Infertility Services by Product in 2024
 Table 168. InVitroCare Revenue Proportion of Infertility Services by Application in 2024
 Table 169. InVitroCare Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 170. InVitroCare Recent Developments
 Table 171. INVO Bioscience Corporation Information
 Table 172. INVO Bioscience Description and Business Overview
 Table 173. INVO Bioscience Infertility Services Product
 Table 174. INVO Bioscience Infertility Services Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 175. INVO Bioscience Revenue Proportion of Infertility Services by Product in 2024
 Table 176. INVO Bioscience Revenue Proportion of Infertility Services by Application in 2024
 Table 177. INVO Bioscience Revenue Proportion of Infertility Services by Geographic Area in 2024
 Table 178. INVO Bioscience Recent Developments
 Table 179. North America Infertility Services Revenue by Country (2020-2025) & (US$ Million)
 Table 180. North America Infertility Services Revenue by Country (2026-2031) & (US$ Million)
 Table 181. North America Infertility Services Revenue by Type (2020-2025) & (US$ Million)
 Table 182. North America Infertility Services Revenue by Application (2020-2025) & (US$ Million)
 Table 183. Asia-Pacific Infertility Services Revenue by Region (2020-2025) & (US$ Million)
 Table 184. Asia-Pacific Infertility Services Revenue by Region (2026-2031) & (US$ Million)
 Table 185. Asia-Pacific Infertility Services Revenue by Type (2020-2025) & (US$ Million)
 Table 186. Asia-Pacific Infertility Services Revenue by Application (2020-2025) & (US$ Million)
 Table 187. Europe Infertility Services Revenue by Country (2020-2025) & (US$ Million)
 Table 188. Europe Infertility Services Revenue by Country (2026-2031) & (US$ Million)
 Table 189. Europe Infertility Services Revenue by Type (2020-2025) & (US$ Million)
 Table 190. Europe Infertility Services Revenue by Application (2020-2025) & (US$ Million)
 Table 191. Latin America Infertility Services Revenue by Country (2020-2025) & (US$ Million)
 Table 192. Latin America Infertility Services Revenue by Country (2026-2031) & (US$ Million)
 Table 193. Latin America Infertility Services Revenue by Type (2020-2025) & (US$ Million)
 Table 194. Latin America Infertility Services Revenue by Application (2020-2025) & (US$ Million)
 Table 195. Middle East and Africa Infertility Services Revenue by Country (2020-2025) & (US$ Million)
 Table 196. Middle East and Africa Infertility Services Revenue by Country (2026-2031) & (US$ Million)
 Table 197. Middle East and Africa Infertility Services Revenue by Type (2020-2025) & (US$ Million)
 Table 198. Middle East and Africa Infertility Services Revenue by Application (2020-2025) & (US$ Million)
 Table 199. Infertility Services Key Raw Materials, Industry Status and Trend
 Table 200. Infertility Services Key Raw Materials and Upstream Suppliers
 Table 201. Infertility Services Clients Status and Trend
 Table 202. Infertility Services Typical Clients
 Table 203. Infertility Services Distributors
 Table 204. Infertility Services Market Trends
 Table 205. Infertility Services Market Drivers
 Table 206. Infertility Services Market Challenges
 Table 207. Infertility Services Market Restraints
 Table 208. Research Programs/Design for This Report
 Table 209. Key Data Information from Secondary Sources
 Table 210. Key Data Information from Primary Sources


List of Figures
 Figure 1. Infertility Services Product Picture
 Figure 2. Global Infertility Services Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Infertility Services Revenue Market Share by Type in 2024 & 2031
 Figure 4. Assisted Reproductive Technology (ART) Product Picture
 Figure 5. Infertility Drug Services Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Infertility Services Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Infertility Services Revenue Market Share by Application in 2024 & 2031
 Figure 9. Male
 Figure 10. Female
 Figure 11. Infertility Services Report Years Considered
 Figure 12. Global Infertility Services Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Infertility Services Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Infertility Services Market Size Market Share by Region: 2024 Versus 2031
 Figure 15. Global Infertility Services Revenue Market Share by Region (2020-2031)
 Figure 16. Global Infertility Services Revenue Market Share Forecast by Type (2020-2031)
 Figure 17. Global Infertility Services Revenue Market Share Forecast by Application (2020-2031)
 Figure 18. Assisted Reproductive Technology (ART) of Infertility Services Revenue Market Share by Application, 2024 VS 2031
 Figure 19. Infertility Drug Services of Infertility Services Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Others of Infertility Services Revenue Market Share by Application, 2024 VS 2031
 Figure 21. Infertility Services Revenue Share by Company (2024)
 Figure 22. Infertility Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Assisted Reproductive Technology (ART) Revenue Proportion by Company in 2024
 Figure 24. Infertility Drug Services Revenue Proportion by Company in 2024
 Figure 25. Others Revenue Proportion by Company in 2024
 Figure 26. North America Infertility Services Revenue 2020-2031 (US$ Million)
 Figure 27. North America Infertility Services Revenue Market Share by Type (2020-2025)
 Figure 28. North America Infertility Services Revenue Market Share by Application (2020-2025)
 Figure 29. Asia-Pacific Infertility Services Revenue 2020-2031 (US$ Million)
 Figure 30. Asia-Pacific Infertility Services Revenue Market Share by Region (2020-2031)
 Figure 31. Asia-Pacific Infertility Services Revenue Market Share by Type (2020-2025)
 Figure 32. Asia-Pacific Infertility Services Revenue Market Share by Application (2020-2025)
 Figure 33. Europe Infertility Services Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 34. Europe Infertility Services Revenue Market Share by Country (2020-2031)
 Figure 35. Europe Infertility Services Revenue Market Share by Type (2020-2025)
 Figure 36. Europe Infertility Services Revenue Market Share by Application (2020-2025)
 Figure 37. Latin America Infertility Services Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Latin America Infertility Services Revenue Market Share by Country (2020-2031)
 Figure 39. Latin America Infertility Services Revenue Market Share by Type (2020-2025)
 Figure 40. Latin America Infertility Services Revenue Market Share by Application (2020-2025)
 Figure 41. Middle East and Africa Infertility Services Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Middle East and Africa Infertility Services Revenue Market Share by Country (2020-2031)
 Figure 43. Middle East and Africa Infertility Services Revenue Market Share by Type (2020-2025)
 Figure 44. Middle East and Africa Infertility Services Revenue Market Share by Application (2020-2025)
 Figure 45. Infertility Services Supply Chain (Upstream and Downstream Market)
 Figure 46. Global Production Market Share of Infertility Services Raw Materials by Region in 2024
 Figure 47. Infertility Services Distribution Channels
 Figure 48. Global Infertility Services Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 49. Global Infertility Services Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 50. Bottom-up and Top-down Approaches for This Report
 Figure 51. Data Triangulation
 Figure 52. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Assisted Reproductive Treatment Market Research Report 2024
Global Male Infertility Testing Market Research Report 2024
Global Infertility Devices Market Insights Forecast to 2030
Global IVF Service Market Research Report 2024
Global Male Infertility Treatment Market Insights Forecast to 2030
In Vitro Fertilization IVF Treatment Market
Global Infertility Therapies Market Insights Forecast to 2030
Global In Vitro Fertilization Service Market Research Report 2025
Global Stem Cell Therapy for Infertility Market Research Report 2024
Global Ultrasound Infertility Diagnosis and Treatment Market Research Report 2022
Global Infertility Diagnosis Market Research Report 2024
Global Infertility Solutions Market Research Report 2025
Global In vitro Fertilization IVF Incubators Market Insights Forecast to 2030
Global Infertility Treatment Drugs Market Insights Forecast to 2030
Global Pet Reproductive Services Market Research Report 2024
Global Infertility Testing Market Research Report 2024
Global Male Infertility Market Research Report 2024
Assistive Reproductive Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
IVF Devices and Consumables Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infertility Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions